The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| POSC | -7.77% | +708.72% | +51.83% | -100% |
| S&P | +13.95% | +78.35% | +12.25% | +1,391% |
Positron Corp. operates as a nuclear medicine healthcare company, which engages in the provision of cardiac positron emission tomography imaging. It operates through the Medical Equipment and Radiopharmaceuticals segments. It offers economical, end-to-end solutions for Positron Emission Tomography (PET) myocardial perfusion imaging through complementary product integration of PET imaging systems, radiopharmaceuticals, and radioisotopes. The company was founded by Roman Oliynyk on December 20, 1983 and is headquartered in Niagara Falls, NY.
No news articles found for Positron.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $111.00K | -18.4% |
| Gross Profit | -$256.16K | -696.3% |
| Gross Margin | -230.78% | -207.1% |
| Market Cap | $21.41M | 50.0% |
| Market Cap / Employee | $2.14M | 0.0% |
| Employees | 10 | 0.0% |
| Net Income | -$1,043.94K | -272.7% |
| EBITDA | -$989.61K | -320.0% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $1.88M | 725.0% |
| Accounts Receivable | $8.33K | 0.0% |
| Inventory | 1.3 | 0.0% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $161.83K | 410.0% |
| Short Term Debt | $1.79M | -13.7% |
| Q1 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -82.70% | -4.1% |
| Return On Invested Capital | 1213.82% | 123.0% |
| Q1 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$1,437.76K | -189.9% |
| Operating Free Cash Flow | -$1,437.76K | -189.9% |
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | -59.00 | -22.35 | -38.27 | 15.46 | -120.75% |
| Price to Sales | 49.35 | 41.90 | 45.17 | 91.77 | 109.38% |
| Price to Tangible Book Value | -59.00 | -22.35 | -38.27 | 15.46 | -120.75% |
| Enterprise Value to EBITDA | -120.70 | -27.50 | -34.19 | -49.58 | -42.79% |
| Return on Equity | -424.8% | -1800.0% | -887.7% | -168.9% | - |
| Total Debt | $2.11M | $1.80M | $1.55M | $1.95M | 14.17% |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
